Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.
复制标题
DOI:
10.1038/mp.2013.61
复制
发表时间:
2013-09
影响因子:
11
通讯作者:
Huang, Y.
中科院分区:
文献类型:
--
作者:
Neumeister, A.;Normandin, M. D.;Pietrzak, R. H.;Piomelli, D.;Zheng, M. Q.;Gujarro-Anton, A.;Potenza, M. N.;Bailey, C. R.;Lin, S. F.;Najafzadeh, S.;Ropchan, J.;Henry, S.;Corsi-Travali, S.;Carson, R. E.;Huang, Y.
Endocannabinoids and their attending cannabinoid type 1 receptor (CB1) have been implicated in animal models of posttraumatic stress disorder (PTSD). However, their specific role has not been studied in people with PTSD. Herein, we present an in vivo imaging study using positron emission tomography (PET) and the CB1-selective radioligand [11C]OMAR in individuals with PTSD, and healthy controls with lifetime histories of trauma (trauma controls [TC]) and those without such histories (healthy controls [HC]). Untreated individuals with PTSD (N=25) with non-combat trauma histories, and TC (N=12) and HC (N=23) participated in a magnetic resonance (MR) imaging scan and a resting PET scan with the CB1 receptor antagonist radiotracer [11C]OMAR, which measures volume of distribution (VT) linearly related to CB1 receptor availability. Peripheral levels of anandamide, 2-arachidonoylglycerol (2-AG), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and cortisol were also assessed. In the PTSD group, relative to the HC and TC groups, we found elevated brain-wide [11C]OMAR VT values (F(2,53)=7.96, p=.001; 19.5% and 14.5% higher, respectively) which were most pronounced in women (F(1,53)=5.52, p=.023). Anandamide concentrations were reduced in the PTSD relative to the TC (53.1% lower) and HC (58.2% lower) groups. Cortisol levels were lower in the PTSD and TC groups relative to the HC group. Three biomarkers examined collectively—OMAR VT, anandamide, and cortisol—correctly classified nearly 85% of PTSD cases. These results suggest that abnormal CB1 receptor-mediated anandamide signaling is implicated in the etiology of PTSD, and provide a promising neurobiological model to develop novel, evidence-based pharmacotherapies for this disorder.
登录
查看更多内容
DOI:
10.1523/jneurosci.4283-10.2010
发表时间:
2010-11-10
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Hill MN;Patel S;Campolongo P;Tasker JG;Wotjak CT;Bains JS
通讯作者:
Bains JS
影响因子:
3.5
作者:
de Jong, Hugo W. A. M.;van Velden, Floris H. P.;Lammertsma, Adriaan A.
通讯作者:
Lammertsma, Adriaan A.
影响因子:
3.8
作者:
GANDELMAN, MS;BALDWIN, RM;INNIS, RB
通讯作者:
INNIS, RB
影响因子:
6.1
作者:
Beyer, Chad E.;Dwyer, Jason M.;Whiteside, Garth T.
通讯作者:
Whiteside, Garth T.
影响因子:
4.4
作者:
Cornelius, Jack R.;Kirisci, Levent;Tarter, Ralph
通讯作者:
Tarter, Ralph